1609529-70-5
1609529-70-5
Chemical Structure
Deucravacitinib analog 1
- CAS No.: 1609529-70-5
- Formula:C27H26FN7O3
- Molecular Weight:515.54
InChIKey: OXIRLLVPYPWPEK-UHFFFAOYSA-N
SMILES: O=C(C1=CC=CC(NC2=CC(NC3=CC(C)=C(F)C=N3)=NC=C2C(NC)=O)=C1OC)NCC4=CC=CC=N4
Biological Activity: Deucravacitinib analog 1 (compound 3), Deucravacitinib (HY-117287) derivative, is a TYK2 allosteric ligand. Deucravacitinib analog 1 binds to the JH2 domain of TYK2. Deucravacitinib analog 1 serves as a starting point for development of TYK2-targeting PROTAC degraders. Deucravacitinib analog 1 can be used for the researches of psoriasis and cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Deucravacitinib analog 1 | Deucravacitinib analog 1 (compound 3), Deucravacitinib (HY-117287) derivative, is a TYK2 allosteric ligand. Deucravacitinib analog 1 binds to the JH2 domain of TYK2. Deucravacitinib analog 1 serves as a starting point for development of TYK2-targeting PROTAC degraders. Deucravacitinib analog 1 can be used for the researches of psoriasis and cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
